Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study) - Nakaoka, Y; Isobe, M; Takei, S (Ann Rheum Dis, 2018)
et al.